Upon interaction with specific BC cells, EV-RN7SL1 from activated fibroblasts is devoid of SRP9/14 shielding to activate RIG-I in the BC cells, leading to inflammation, tumor growth, metastasis, and therapy resistance [193]. This evidence concerns the gene RIGI and neoplasm.